SIECUS Releases New Reviews of Commonly Used, Federally Funded Abstinence-Only-Until-Marriage Curricula
As part of its Fourth Annual “Back to School” briefing, held October…
General Articles
Read MoreSIECUS Releases New Reviews of Commonly Used, Federally Funded Abstinence-Only-Until-Marriage Curricula
Representatives Question Abstinence-Until-Marriage Funding Requirement
On September 6, 2006, the U.S. House of Representatives Committee on Government…
California Family Planning Program Successfully Averts Thousands of Unplanned Pregnancies
California’s Family PACT (Planning, Access, Care, and Treatment), California’s family planning program…
Anti-Choice Groups Target People of Color
Two of the nation’s leading anti-choice groups, Heartbeat International and Care Net,…
Article Details HIV/AIDS Infection Among Young People
A recent Journal of Adolescent Health article titled “Epidemiology of HIV and…
India Plans to Primarily Promote Condom Use for HIV Prevention
Recently, India announced that 80% of funding in the government’s new 5…
New Report Outlines Progressive Vision for Reproductive Health and Rights
On September 13, 2006, the Center for American Progress released a report…
House Democrats Introduce Reducing the Need for Abortion and Supporting Parents Act
Representative Tim Ryan (D-IL), who opposes abortion rights, and Representative Rosa DeLauro…
South Carolina Comprehensive Sexuality Education Program Successfully Lowers Teen Pregnancy Rate
A comprehensive sexuality education program in Bamberg County, SC has effectively reduced…
FDA Approves Over-the-Counter Access to Plan B for Women 18 Years and Older; Young Women Still Require Prescription
In what sexual and reproductive health and rights advocates consider to be…
CREW Requests IRS Review of Abstinence Clearinghouse
Citizens for Responsibility and Ethics in Washington (CREW) recently requested an IRS…
Growing epidemic of HIV/AIDS among Men Who Have Sex with Men (MSM) In Asian-Pacific Countries
A recent report produced by The Foundation for AIDS Research’s (amfAR’s) Therapeutics…